Ruth Gabriela Herrera Gómez

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 232 citations

Medicine, Oncology, Chemotherapy +14

Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Khalil Saleh, Amaury Daste, Nicolas Martin et al. · European Journal of Cancer · 2019 · 183 citations

Medicine, Oncology, Chemotherapy +10

Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma

Antoine Moya‐Plana, Ruth Gabriela Herrera Gómez, Caroline Rossoni et al. · Cancer Immunology Immunotherapy · 2019 · 88 citations · Full text

Medicine, Immunology, Oncology +12

Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4

Romain‐David Seban, Antoine Moya‐Plana, Lara Antonios et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 81 citations

Medicine, Immunology, Oncology +17

Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastoma

David H. Abramson, Christopher M. Frank, Guillermo Chantada et al. · Ophthalmic Genetics · 1999 · 34 citations

Medicine, Ophthalmology, Pharmacology +15